search
Drug Topics
Trends
- 1Weight loss drugs may help treat reproductive health issues▼Weight loss drugs could help treat women’s reproductive health issues, experts say
Health experts say weight loss drugs such as GLP-1 medications could offer benefits beyond slimming, potentially helping treat women's reproductive health issues. The suggestion points to a possible new use for a class of medicines already in high demand, and it is drawing attention to how obesity-related treatments might intersect with conditions like polycystic ovary syndrome and fertility problems.
- 2AI Clinical Monitoring Tool Reported to Cut Trial Costs by Millions▼AI Clinical Monitoring Tool Saves Millions in Trial Costs
An AI-powered clinical monitoring tool is reported to have saved millions of dollars in clinical trial costs, according to coverage in The Scientist. The tool is said to streamline monitoring of trial sites, reducing manual oversight work and associated expenses. The report highlights growing interest in applying artificial intelligence to make drug development faster and cheaper, though detailed figures and trial specifics were not provided.
- 3AI helping scientists advance biological design in health research▼How AI is allowing scientists to advance biological design for health research: HealthLink
Scientists are increasingly using artificial intelligence to speed up biological design for health research, applying AI tools to engineer proteins, model biological systems and accelerate drug and therapy development. The approach is being highlighted as a way to cut research timelines and expand what laboratories can design, with health reporters examining how the technology is changing biomedical science and what it could mean for future treatments.
- 4GLP-1 drugs, mental health and exercise in menopause examined▼GLP-1's and mental health; exercise and menopause
Public health coverage is drawing together two related topics: the possible mental health effects of GLP-1 weight-loss and diabetes drugs, and the role of exercise for women going through menopause. Listeners are weighing reported mood changes linked to GLP-1 medications against growing evidence that physical activity can ease menopause symptoms such as hot flashes, sleep problems and weight gain.
- 5
Brazilian health outlets are publishing advice on managing blood glucose levels before breakfast, recommending simple morning habits to add to daily routines. The topic coincides with renewed attention on weight-loss injections, as a study on retatrutide showed participants losing up to 23.4% of their body weight, keeping blood sugar and metabolic health in the public conversation.
- 6From Failed Experiments to FDA Approval: A Cancer Drug Story▼From Failed Experiments to FDA Approval A simple look at how years of failed experiments, patient participation, and per
A new explorative article traces how a difficult cancer drug target became an FDA-approved medicine, crediting years of failed experiments, patient participation in trials, and persistence in cancer pharmacology. The piece aims to explain in simple terms why most drug development efforts fail and what it takes, scientifically and in patient involvement, to finally bring an approved treatment to market.
- 7
A student from the Rochester Institute of Technology has won HackMIT, a prominent student hackathon, with a low-cost device for testing medicines. The invention aims to make medicine quality checks affordable, a concern in regions where counterfeit or substandard drugs circulate. Details of the student's name and the device's technology have not yet been widely reported.
- 8Wellness roundup: new drug, testosterone, GLP-1 eye risk, salmonella▼Wellness Wednesday: Cychlorphine, testosterone levels, GLP-1 and vision loss, jalapeño salmonella outbreak
A health news roundup covers four topics: cychlorphine, a substance drawing attention for potential effects on testosterone levels; possible links between GLP-1 weight-loss and diabetes drugs and vision loss; and an ongoing salmonella outbreak tied to jalapeño peppers. Together the items touch on medication safety, supplement trends and a foodborne illness investigation that health officials are monitoring.
- 9Why Rural Pharmacies Choose Trust Over Technology▼Q&A: Why Rural Pharmacies Prioritize Trust Over Technology
Drug Topics has published a Q&A exploring why rural pharmacies place personal trust and community relationships ahead of new technology. The piece examines how independent pharmacists in remote areas rely on long-standing patient relationships rather than digital tools to serve their communities. The discussion highlights a tension in healthcare between modernization and the personal touch that defines small-town pharmacy practice.
- 10Pfizer highlights AI's role in speeding clinical trial matching●How AI Is Helping Match Patients to Clinical Trials Faster
Pfizer is drawing attention to how artificial intelligence is being used to match patients to clinical trials more quickly. AI tools can scan patient records and trial criteria far faster than manual screening, helping to address the long-standing problem that many trials struggle to enrol enough participants. The topic is part of a wider debate about AI's growing role in drug development and patient care.
- 11FAQ Released on Pharmacists' Understanding of mRNA Vaccine Technology▼FAQ: Pharmacist Understanding of mRNA Vaccine Technology
Drug Topics has published a FAQ addressing how well pharmacists understand mRNA vaccine technology. The piece answers common questions about the science behind mRNA vaccines and what pharmacists should know when advising patients. It reflects continued professional interest in keeping pharmacy staff up to date on vaccine technology and public communication.
- 12AAPS PharmSci 360 Brings New Insights for Pharma Scientists▼AAPS PharmSci 360 Offers Fresh Insights for Industry Scientists
The AAPS PharmSci 360 conference is presenting new research and perspectives for scientists working across the pharmaceutical industry. Coverage highlights fresh insights on drug discovery and development shared at the event, which gathers industry professionals to discuss scientific advances, regulatory topics, and emerging technologies shaping the pharma field.